BSE Live
Nov 10, 16:01Prev. Close
414.40
Open Price
410.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 10, 15:58Prev. Close
414.60
Open Price
410.20
Bid Price (Qty.)
405.85 (46)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -24.99 | 4.34 | -11.73 | -11.86 | 0.14 | |
| Diluted EPS (Rs.) | -24.99 | 4.34 | -11.73 | -11.86 | 0.14 | |
| Cash EPS (Rs.) | -20.60 | 9.73 | -6.23 | -1.06 | 11.78 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 142.19 | 66.75 | 61.79 | 72.85 | 85.44 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 142.19 | 66.75 | 61.79 | 72.85 | 85.44 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 25.81 | 15.71 | 29.99 | 86.54 | 105.53 | |
| PBDIT/Share (Rs.) | -5.12 | -23.37 | 0.72 | 20.11 | 22.52 | |
| PBIT/Share (Rs.) | -9.51 | -28.76 | -4.78 | 9.31 | 10.89 | |
| PBT/Share (Rs.) | -12.89 | 5.31 | -21.64 | -13.72 | 0.23 | |
| Net Profit/Share (Rs.) | -24.99 | 4.34 | -11.73 | -11.86 | 0.14 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -19.83 | -148.77 | 2.39 | 23.23 | 21.34 | |
| PBIT Margin (%) | -36.85 | -183.10 | -15.94 | 10.75 | 10.31 | |
| PBT Margin (%) | -49.92 | 33.83 | -72.13 | -15.85 | 0.21 | |
| Net Profit Margin (%) | -96.82 | 27.61 | -39.12 | -13.70 | 0.13 | |
| Return on Networth / Equity (%) | -17.57 | 6.49 | -18.99 | -16.28 | 0.16 | |
| Return on Capital Employed (%) | -6.01 | -33.81 | -2.96 | 4.78 | 5.00 | |
| Return on Assets (%) | -13.44 | 1.84 | -4.29 | -4.07 | 0.04 | |
| Total Debt/Equity (X) | 0.07 | 0.36 | 2.00 | 2.07 | 1.90 | |
| Asset Turnover Ratio (%) | 13.88 | 6.67 | 10.97 | 29.75 | 35.79 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.60 | 0.99 | 0.52 | 0.69 | 0.71 | |
| Quick Ratio (X) | 3.02 | 0.95 | 0.30 | 0.46 | 0.43 | |
| Inventory Turnover Ratio (X) | 1.59 | 2.26 | 1.23 | 3.77 | 4.74 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 674.08 | 1,363.81 | 2,388.72 | 1,910.78 | 1,572.97 | |
| EV/Net Operating Revenue (X) | 4.26 | 14.18 | 13.00 | 3.60 | 2.43 | |
| EV/EBITDA (X) | -21.50 | -9.53 | 543.39 | 15.52 | 11.39 | |
| MarketCap/Net Operating Revenue (X) | 4.24 | 12.62 | 8.90 | 1.86 | 0.88 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.77 | 2.97 | 4.32 | 2.21 | 1.09 | |
| Price/Net Operating Revenue | 4.24 | 12.62 | 8.90 | 1.86 | 0.88 | |
| Earnings Yield | -0.23 | 0.02 | -0.04 | -0.07 | 0.00 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y